Back to search

Article

The frequency of ctDNA with KRAS, NRAS, and BRAF mutations in colorectal cancer is associated with the mutation site

2023-11-29

Abstract excerpt

<title>Abstract</title> <p>Early prediction of metastatic risk after tumor resection for colorectal cancer (CRC) is critical to improve treatment outcomes. Although circulating tumor DNA (ctDNA) is an important biomarker in CRC patients, methods and cutoff values have not been clearly established. In this study, we examined the relationship between mutatnt allele frequency (MAF) and the genetic mutation site and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7f588bf1-15a7-5148-811c-4c98af23aad7
DOI
10.21203/rs.3.rs-3656938/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The frequency of ctDNA with KRAS, NRAS, and BRAF mutations in colorectal cancer is associated with the mutation siteDOI 10.21203/rs.3.rs-3656938/v1
Site-Specific Mutations on KRAS, NRAS, and BRAF Corelate With the Frequency of ctDNA in Colorectal Cancer.Semantic proximity
Relationship between perioperative oncological evaluation and recurrence using circulating tumor DNA with KRAS mutation in patients with colorectal cancer.Semantic proximity
RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.Semantic proximity
Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancerSemantic proximity
Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer.Semantic proximity
Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.Semantic proximity
Clinical Validation of Plasma-Based Genotyping for RAS and BRAF V600E Mutation in Metastatic Colorectal Cancer: SCRUM-Japan GOZILA Substudy.Semantic proximity
Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancerSemantic proximity
Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study.Semantic proximity
Analysis of circulating tumor DNA to predict risk of recurrence in patients with esophageal and gastric cancersSemantic proximity
Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.Semantic proximity
Circulating tumour DNA at baseline for individualised prognostication in patients with chemotherapy-naïve metastatic colorectal cancer. An AGEO prospective study.Semantic proximity
Select a neighboring publication to make it the new centre.